Evidence map›Paper›PMID 28674456›Full record

ArticleScientific reports2017

PAX2 is dispensable for in vitro nephron formation from human induced pluripotent stem cells.

Yusuke Kaku, Atsuhiro Taguchi, Shunsuke Tanigawa, Fahim Haque, Tetsushi Sakuma, Takashi Yamamoto, Ryuichi Nishinakamura

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Comparative analysis ofbioRxiv : the preprint server for biology · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. International journal of molecular sciences · 2023
    Review
  9. Harnessing mechanobiology for kidney organoid research.Frontiers in cell and developmental biology · 2023
    Review
  10. Engraftment of Kidney Organoids In Vivo.Current transplantation reports · 2023
    Review
  11. Kidney organoids: a pioneering model for kidney diseases.Translational research : the journal of laboratory and clinical medicine · 2022
    Review
  12. Article
  13. STAR protocols · 2021
    Article
  14. Article
  15. Review
  16. Stem cell-derived kidney organoids: engineering the vasculature.Cellular and molecular life sciences : CMLS · 2020
    Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yusuke KakuDepartment of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.
Atsuhiro TaguchiDepartment of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.
Shunsuke TanigawaDepartment of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.
Fahim HaqueDepartment of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.ORCID 0000-0001-6347-1836
Tetsushi SakumaDepartment of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan.
Takashi YamamotoDepartment of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan.
Ryuichi NishinakamuraDepartment of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan. ryuichi@kumamoto-u.ac.jp.
Kumamoto University · JPHiroshima University · JPKumamoto Industrial Research Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The kidney is formed by reciprocal interactions between the nephron progenitor and the ureteric bud, the former of which gives rise to the epithelia of nephrons consisting of glomeruli and renal tubules. The transcription factor PAX2 is essential for this mesenchymal-to-epithelial transition of nephron progenitors, as well as ureteric bud lineage development, in mice. PAX2 mutations in humans cause renal coloboma syndrome. We previously reported the induction of nephron progenitors and three-dimensional nephron structures from human induced pluripotent stem (iPS) cells. Here we generate iPS cells lacking PAX2, and address the role of PAX2 in our in vitro induction protocol. While PAX2-null human nephron progenitors were properly formed, they unexpectedly became epithelialised to form glomeruli and renal tubules. However, the mutant glomerular parietal epithelial cells failed to transit to the squamous morphology, retaining the shape and markers of columnar epithelia. Therefore, PAX2 is dispensable for mesenchymal-to-epithelial transition of nephron progenitors, but is required for morphological development of glomerular parietal epithelial cells, during nephron formation from human iPS cells in vitro.

Indexed as

BiomarkersCell DifferentiationEpithelial-Mesenchymal TransitionFluorescent Antibody TechniqueGene ExpressionGene Knockout TechniquesGenotypeHumansInduced Pluripotent Stem CellsIn Vitro TechniquesKidney GlomerulusKidney TubulesNephronsOrganogenesisPAX2 Transcription FactorBiomarkersPAX2 Transcription Factor

Identifiers

PMID28674456
PMCPMC5495778
OpenAlexW2730883636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.